И его применение при заболеваниях легких



Pdf көрінісі
бет26/29
Дата02.11.2022
өлшемі142,06 Kb.
#156206
1   ...   21   22   23   24   25   26   27   28   29
Байланысты:
1089-757-1-PB

Clark H., Palaniyar N., Strong P. et al.
Surfactant protein reduces alveo
lar macrophage apoptosis 
in vivo
. J. Immunol. 2002; 169 (6): 2892—2899. 
74. 
Clark H. W., Palaniyar N., Hawgood S. et al.
A recombinant fragment of
human surfactant protein D reduces alveolar macrophage apoptosis and
proinflammatory cytokones in mice developing pulmonary emphyse
ma. Ann. N. Y. Acad. Sci. 2003; 1010: 113—116. 
75. 
Kaplan J. H., Casey J. A., Savani R. C. et al.
Differential response of col
lectin deficient mouse models to bleomycin induced lung injury. Appl.
Cardiopulm. Pathophysiol. 2004; 13 (1): 51—52. 
76. 
Lewis J., Veldhuizen R.
The role of surfactant in the pathophysiology of
acute lung injury. Appl. Cardiopulm. Pathophysiol. 2004; 13 (1): 53—55. 
77. 
Clark J. C., Wert S. E., Bachurski C. J. et al.
Targeted disruption of the sur
factant protein B gene disrupts surfactant homeostasis, causing respira
tory failure in newborn mice. Proc. Natl. Acad. Sci. USA 1995; 92 (17):
7794—7798. 
78. 
Nogee L. M., Garnier G., Dietz H. C. et al.
A mutation in the surfactant
protein B gene responsible for fatal neonatal respiratory disease in mul
tiple kindreds. J. Clin. Invest. 1994; 93 (4): 1860—1863. 
79. 
Melton K. R., Nesslein L. L., Ikegami M. et al. 
SPB deficiency causes res
piratory failure in adult mice. Am. J. Physiol. 2003; 285: 543—549. 
80. 
Cochrane C. G. 
A critical examination of the role of SPB in alveolar
expansion, Appl. Cardiopulm. Pathophysiol. 2004; 13 (1): 27—29. 
81. 
Cruz A., Vazquez L., Bernardinjo J. et al.
Analysis by scanning force
microscopy of the micro and nanostructure of LangmuirBlodgett pul
monary surfactant films. Appl. Cardiopulm. Pathophysiol. 2004; 13: 30—31. 
82. 
Cruz A. et al. 
Effect of pulmonary surfactant protein SPB on the micro
and nanostructure of phospholipids films. Biophys. J. 2004; 86: 308—310. 
83. 
Na Nkorn P., Flach C. R., Mendelsohn R. et al.
The influence of truncat
ed surfactantprotein C (SPC17) on the surface properties of lipid
monolayers at the airwater interface. Appl. Cardiopulm. Pathophysiol.
2004; 13 (1): 62—63. 
84. 
Weaver T. E., Conkright J. J.
Function of surfactant proteins B and C.
Annu. Rev. Physiol. 2001; 63: 555—578. 
85. 
Cotton R. B., Olsson T.
Lung mechanics in respiratory distress syndrome.
In: Robertson B., Taeusch H. W. (eds.) Surfactant therapy for lung dis
ease. Lung biology in health and disease. N. Y.: Marcel Dekker, Inc.;
1995; 84. 121—150. 
86. 
Floros J., Veletza V., Kotikalapudi P. et al.
Dinucleotide repeats in the
human surfactant protein B gene and respiratory distress syndrome.
Biochem. J. 1995; 305: 583—590. 
87. 
Nogee L. M., deMello D. E., Dehner L. P. et al.
Deficiency of pulmonary surfac
tant protein B in alveolar proteinosis. N. Engl. J. Med. 1993; 328: 406—410. 
88. 
Рейниш М. С., Розенберг О. А. 
Быстрый метод определения фосфо
липидов в амниотической жидкости. Лаб. дело 1978; (2): 98—100. 
89. 
Bernard G. R. et al.
The AmericanEuropean consensus conference on
ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial
coordination. Am. J. Respir. Crit. Care Med. 1994; 149: 818—821. 
90. 
Gregory T. J., Longmore W. J., Moxley M. A. et al.
Surfactant chemical
composition and biophysical activity in acute respiratory distress syn
drome. J. Clin. Invest. 1991; 88: 1976—1981. 
91. 
Hallman M., Spragg R., Harrell J. H. et al.
Evidence of lung surfactant
abnormality in respiratory failure. Study of bronchoalveolar lavage
phospholipids, surface activity, phospholipase activity and plasma
myoinositol. J. Clin. Invest. 1982; 70: 673—683. 
92. 


Достарыңызбен бөлісу:
1   ...   21   22   23   24   25   26   27   28   29




©engime.org 2024
әкімшілігінің қараңыз

    Басты бет